BALAXI PHARMACEUTICALS LIMITED approved standalone and consolidated unaudited financial results for the quarter ended June 30, 2024, and an investment in wholly-owned subsidiary Balaxi Global Dubai DMCC up to USD 5 million.
AI Assistant
Balaxi Pharmaceuticals Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.